Mass Treatment with Single-Dose Azithromycin for Trachoma
Top Cited Papers
Open Access
- 4 November 2004
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 351 (19) , 1962-1971
- https://doi.org/10.1056/nejmoa040979
Abstract
Trachoma, caused by repeated ocular infection with Chlamydia trachomatis, is an important cause of blindness. Current recommended dosing intervals for mass azithromycin treatment for trachoma are based on a mathematical model.Keywords
This publication has 29 references indexed in Scilit:
- Does the Diagnosis of Trachoma Adequately Identify Ocular Chlamydial Infection in Trachoma‐Endemic Areas?The Journal of Infectious Diseases, 2003
- Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?Ophthalmic Epidemiology, 2002
- Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organismsInternational Journal of Systematic and Evolutionary Microbiology, 1999
- A Comparison of Oral Azithromycin with Topical Oxytetracycline/Polymyxin for the Treatment of Trachoma in ChildrenClinical Infectious Diseases, 1997
- Randomised controlled trial of single-dose azithromycin in treatment of trachomaPublished by Elsevier ,1993
- Trachoma--the future for a disease of the past.British Journal of Ophthalmology, 1993
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Overview of Chlamydia trachomatis Infection and the Requirements for a VaccineClinical Infectious Diseases, 1985
- Development of Trachoma Control Programs and the Involvement of National ResourcesClinical Infectious Diseases, 1985
- Rifampin in Chlamydial InfectionsClinical Infectious Diseases, 1983